Retina Associates of Western New York

Rochester, New York 14618

We've found

4 trials

at this facility

DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Rochester, NY

Evaluating Abicipar for Safety and Treatment Effect in Patients With Neovascular Age-related Macular Degeneration (AMD)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Rochester, NY

PROMINENT-Eye Ancillary Study (Protocol AD)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Rochester, NY

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

Status: Upcoming, Phase III
Updated: 12/31/1969

from

Rochester, NY

Use our guide to learn which trials are right for you!